Dr. Zirwas discusses clinical impacts of notable additions to the dermatology literature this year—including 1% diclofenac gel for acne keloidalis nuchae and pseudofolliculitis barbae and oral roflumilast for inflammatory dermatoses.

Dr. Marghoob discusses dysplastic nevi as markers of increased risk for melanoma, then elaborates on optimal approaches to detection, screening, monitoring, and biopsy of these...
PLAY